Beijing Tongrentang Co., Ltd (SHA:600085)
China · Delayed Price · Currency is CNY 27.63
-0.45 (-1.60%)
Apr 9, 2026, 3:00 PM CST
Beijing Tongrentang Revenue
In the year 2025, Beijing Tongrentang had annual revenue of 17.26B CNY, down -7.21%. Beijing Tongrentang had revenue of 3.95B in the quarter ending December 31, 2025, a decrease of -17.36%.
Revenue
17.26B
Revenue Growth
-7.21%
P/S Ratio
2.20
Revenue / Employee
998.39K
Employees
17,883
Market Cap
37.89B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 17.26B | -1.34B | -7.21% |
| Dec 31, 2024 | 18.60B | 736.39M | 4.12% |
| Dec 31, 2023 | 17.86B | 2.49B | 16.19% |
| Dec 31, 2022 | 15.37B | 769.32M | 5.27% |
| Dec 31, 2021 | 14.60B | 1.78B | 13.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| China Resources Sanjiu Medical & Pharmaceutical | 31.60B |
| Humanwell Healthcare (Group) | 23.96B |
| Changchun High-Tech Industry (Group) | 12.88B |
| Livzon Pharmaceutical Group | 12.02B |
| Dong-E-E-Jiao | 6.70B |
| Hubei Jumpcan Pharmaceutical | 6.14B |
| Shijiazhuang Yiling Pharmaceutical | 6.01B |
| Kangmei Pharmaceutical | 5.28B |